ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week

Phase 4

Terminated

• Conditions: Osteoporosis

• Registration Number: NCT00544180
• Lead Sponsor: Sanofi

Brief Summary

To determine the satisfaction of subject with Actonel 35 mg Once a Week in the treatment of post-menopausal osteoporosis. Open, non-controlled, multi-center study.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-05
• Primary Completion: 2006-09
• Study First Submitted: 2007-10-15
• Study First Submitted QC: 2007-10-15
• Study First Posted: 2007-10-16
• Status Verified: 2009-09
• Last Update Submitted: 2009-09-24
• Last Update Posted: 2009-09-25

Recruitment & Eligibility

• Status: TERMINATED
• Sex: Female
• Target Recruitment: 7

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Patient satisfaction and compliance	During all the study

Trial Locations

Locations (1)

Sanofi-Aventis; 🇮🇱 Natanya, Israel